1. Home
  2. SVRE vs HUGE Comparison

SVRE vs HUGE Comparison

Compare SVRE & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRE
  • HUGE
  • Stock Information
  • Founded
  • SVRE 2014
  • HUGE 1998
  • Country
  • SVRE Israel
  • HUGE Canada
  • Employees
  • SVRE N/A
  • HUGE N/A
  • Industry
  • SVRE
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVRE
  • HUGE Health Care
  • Exchange
  • SVRE Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • SVRE 8.0M
  • HUGE 7.8M
  • IPO Year
  • SVRE 2022
  • HUGE N/A
  • Fundamental
  • Price
  • SVRE $0.36
  • HUGE $0.15
  • Analyst Decision
  • SVRE
  • HUGE
  • Analyst Count
  • SVRE 0
  • HUGE 0
  • Target Price
  • SVRE N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • SVRE 270.3K
  • HUGE 2.4M
  • Earning Date
  • SVRE 08-27-2024
  • HUGE 07-22-2024
  • Dividend Yield
  • SVRE N/A
  • HUGE N/A
  • EPS Growth
  • SVRE N/A
  • HUGE N/A
  • EPS
  • SVRE N/A
  • HUGE N/A
  • Revenue
  • SVRE $2,720,000.00
  • HUGE N/A
  • Revenue This Year
  • SVRE $219.30
  • HUGE N/A
  • Revenue Next Year
  • SVRE $148.59
  • HUGE N/A
  • P/E Ratio
  • SVRE N/A
  • HUGE N/A
  • Revenue Growth
  • SVRE 331.06
  • HUGE N/A
  • 52 Week Low
  • SVRE $0.26
  • HUGE $0.13
  • 52 Week High
  • SVRE $1.50
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • SVRE 42.51
  • HUGE 31.94
  • Support Level
  • SVRE $0.35
  • HUGE $0.14
  • Resistance Level
  • SVRE $0.39
  • HUGE $0.15
  • Average True Range (ATR)
  • SVRE 0.04
  • HUGE 0.02
  • MACD
  • SVRE 0.01
  • HUGE 0.01
  • Stochastic Oscillator
  • SVRE 36.50
  • HUGE 35.19

About SVRE SaverOne 2014 Ltd.

Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: